• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now

    10/31/23 7:00:00 AM ET
    $AGBA
    $AMPE
    $CING
    $COCH
    Investment Managers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGBA alert in real time by email

    MIAMI, Oct. 31, 2023 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 64th Emerging Growth Conference on November 1st and 2nd, 2023.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the conference here.

    Submit Questions for any of the presenting companies to:

    Questions@EmergingGrowth.com

    For updates, follow us on Twitter

    Day 1

    November 1, 2023

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 - 9:35

    AGBA Group Holding Limited (NASDAQ:AGBA)

    Keynote speaker: Mr. Wing-Fai Ng, Group President of AGBA Group

    9:40 - 10:10

    Battery Mineral Resources Corp., (OTCQB:BTRMF) (TSXV:BMR)

    KeKeynote speaker: Martin Kostuik, President / CEO

    10:15 - 10:45

    Envoy Medical, Inc. (NASDAQ:COCH)

    Keynote speaker: Brent Lucas, CEO & David R. Wells, CFO

    10:50 - 11:20

    Houston Natural Resources Corp. (OTC:HNRC)

    Keynote speaker: Frank Kristan, Chairman & CEO

    11:25 - 11:55

    Electronic Servitor Publication Network Inc. (OTCQB:XESP)

    Keynote speaker: Peter Hager, President / CEO

    12:00 - 12:30

    Jaguar Health, Inc. (NASDAQ:JAGX)

    Keynote speaker: Lisa A. Conte, Founder, CEO, President & Director

    12:35 - 1:05

    Ocean Biomedical, Inc. (NASDAQ:OCEA)

    Keynote speakers:

    Dr. Chirinjeev Kathuria, Co-founder / Chairman,

    Elizebeth Ng, CEO,

    Dr. Jonathan Kurtis, Scientific Co-founder & Director of the MD/PhD program Brown University,

    Gurinder Kalra, CFO,

    Daniel Behr, EVP of Academic Partnerships,

    Dr. Inderjote Kathuria, Chief Strategy Officer

    1:10 - 1:40

    GPO Plus, Inc. (OTCQB:GPOX)

    Keynote speaker: Brett Pojunis, President / CEO

    Postponed to December 6

    Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP)

    Keynote speaker: David Mehalick, President / CEO

    2:20 - 2:50

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO & Harry M. Lander, Ph.D. Senior Scientific Consultant

    2:55 - 3:05

    Renforth Resources, Inc. (OTCQB:RFHRF) (CSE:RFR)

    Keynote speaker: Nicole Brewster, President & CEO

    3:10 - 3:20

    Ideal Power (NASDAQ:IPWR)

    Keynote speaker: Dan Brdar, President / CEO, & Tim Burns, CFO

    3:25 - 3:35

    Steppe Gold, Ltd. (OTCQX:STPGF) (TSX:STGO)

    Keynote speakers: Aneel Singh, Exec. VP & Director

    3:40 - 3:50

    NeuroMetrix, Inc. (NASDAQ:NURO)

    Keynote speaker: Dr. Shai Gozani, CEO & Thomas Higgins, CFO

    3:55 - 4:05

    RedCloud Technologies, a Private Company

    Keynote speaker: Justin Floyd, CEO

    Day 2

    November 2, 2023

    10:00

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:35

    Introduction

    10:15 - 10:45

    Sonim Technologies, Inc. (NASDAQ:SONM)

    Keynote speaker: Hao Liu, CEO

    10:50 - 11:20

    Quantum Computing Inc., (NASDAQ:QUBT)

    Keynote speakers: Robert Liscouski, CEO, & Chris Boehmler, CFO

    11:25 - 11:55

    Gold Terra Resource Corp. (OTCQX:YGTFF) (TSXV:YGT)

    Keynote speaker: Gerald Sylvain Panneton, CEO

    12:00 - 12:30

    Independence Contract Drilling, Inc. (NYSE:ICD)

    Keynote speaker: Anthony Gallegos, President / CEO & Director

    12:35 - 1:05

    BioHarvest Sciences Inc. (OTCQB:CNVCF) (CSE:BHSC)

    Keynote speaker: Ilan Sobel, CEO

    1:10 - 1:40

    Ampio Pharmaceuticals, Inc. (NYSE:AMPE)

    Keynote speaker: Michael Martino, CEO & Director

    1:45 - 2:15

    Medicus Pharma Ltd. (TSXV:MDCX)

    Keynote speaker: Carolyn Bonner, President

    Postponed to December 6

    Cingulate Inc. (NASDAQ:CING)

    Keynote speaker: Shane Schaffer, CEO

    2:55 - 3:05

    Loop Industries, Inc. (NASDAQ:LOOP)

    Keynote speaker: Kevin C. O'Dowd, VP Communications

    3:10 - 3:20

    Theriva Biologics Inc., (NYSE:TOVX)

    Keynote speaker: Dr. Manel Cascallo', General Director

    3:25 - 3:35

    Alpha Tau Medical, Inc. (NASDAQ:DRTS)

    eynote speaker: Raphi Levy, CFO

    3:55 - 4:05

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speaker: David Dodd, Chairman, President / CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the conference here.

    Submit Questions for any of the presenting companies to:

    Questions@EmergingGrowth.com

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: Conference@EmergingGrowth.com



    Primary Logo

    Get the next $AGBA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGBA
    $AMPE
    $CING
    $COCH

    CompanyDatePrice TargetRatingAnalyst
    Quantum Computing Inc.
    $QUBT
    9/18/2025$24.00Buy
    Lake Street
    Quantum Computing Inc.
    $QUBT
    7/2/2025$15.00Neutral
    Cantor Fitzgerald
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    Cingulate Inc.
    $CING
    1/10/2025$12.00Buy
    ROTH MKM
    GeoVax Labs Inc.
    $GOVX
    11/11/2024$15.00Buy
    Alliance Global Partners
    GeoVax Labs Inc.
    $GOVX
    7/16/2024$20.00Buy
    ROTH MKM
    Envoy Medical Inc.
    $COCH
    6/24/2024$8.50Buy
    Ascendiant Capital Markets
    More analyst ratings

    $AGBA
    $AMPE
    $CING
    $COCH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quantum Computing Inc. Announces Agreement to Acquire Luminar Semiconductor, Inc. to Accelerate Technology Roadmap

    HOBOKEN, N.J., Dec. 15, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, quantum optics and integrated photonics technology company, today announced that it has signed an agreement (the "Stock Purchase Agreement") to acquire Luminar Semiconductor, Inc. ("LSI"), a wholly owned subsidiary of Luminar Technologies, Inc. ("Luminar") (NASDAQ:LAZR), in an all-cash transaction valued at $110 million (the "Transaction"), subject to customary adjustments. The acquisition will bring QCi a portfolio of core photonic technologies, patents, and a highly experienced team of engineers and scientists that will accelerate QCi's roadmap while continuing to supp

    12/15/25 11:40:00 AM ET
    $LAZR
    $QUBT
    Auto Parts:O.E.M.
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology

    Luminar Announces Sale of Photonics Business to Quantum Computing Inc. for $110 Million

    Luminar Technologies, Inc. (NASDAQ:LAZR) (the "Company" or "Luminar"), a leading global technology company, today announced that it has entered into an agreement with Quantum Computing Inc. ("QCi") pursuant to which QCi will acquire Luminar Semiconductor, Inc. ("LSI"), a wholly owned subsidiary of Luminar, in an all-cash transaction valued at $110 million. QCi is an integrated photonics and quantum optics technology company with a focus on photonics-driven technologies and advanced sensing applications. LSI's innovation platform and engineering depth complement QCi's existing capabilities and long-term strategic priorities in optical systems, chip-scale innovation, and high-reliability pho

    12/15/25 10:40:00 AM ET
    $LAZR
    $QUBT
    Auto Parts:O.E.M.
    Consumer Discretionary
    Computer Software: Prepackaged Software
    Technology

    /C O R R E C T I O N -- Quantum Computing Inc./

    In the news release, Ci Brings Quantum Out of the Lab and Goes Live at CES 2026, issued 10-Dec-2025 by Quantum Computing Inc. over PR Newswire, we are advised by the company that the original version contained a typo introduced by PR Newswire during transmission. The complete, corrected release follows, with additional details at the end: QCi Brings Quantum Out of the Lab and Goes Live at CES 2026 Quantum Computing Inc. debuts at CES Foundry with live demos that show quantum delivering clearer insights, smarter decisions, and safer real-world communication HOBOKEN, N.J., Dec. 10, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, integrated

    12/10/25 8:30:00 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    $AGBA
    $AMPE
    $CING
    $COCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hart Spencer bought $66,070 worth of shares (50,000 units at $1.32), increasing direct ownership by 14% to 410,370 units (SEC Form 4)

    4 - Loop Industries, Inc. (0001504678) (Issuer)

    11/12/25 4:33:21 PM ET
    $LOOP
    Major Chemicals
    Industrials

    Chief Medical Officer Mckee Kelly T. Jr. bought $742 worth of shares (1,107 units at $0.67), increasing direct ownership by 46% to 3,494 units (SEC Form 4)

    4 - GeoVax Labs, Inc. (0000832489) (Issuer)

    8/8/25 3:13:56 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Hart Spencer bought $33,100 worth of shares (20,000 units at $1.66), increasing direct ownership by 6% to 360,370 units (SEC Form 4)

    4 - Loop Industries, Inc. (0001504678) (Issuer)

    8/7/25 8:10:14 PM ET
    $LOOP
    Major Chemicals
    Industrials

    $AGBA
    $AMPE
    $CING
    $COCH
    SEC Filings

    View All

    Theriva Biologics Inc. filed SEC Form 8-K: Other Events

    8-K - Theriva Biologics, Inc. (0000894158) (Filer)

    12/15/25 5:21:47 PM ET
    $TOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Quantum Computing Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Quantum Computing Inc. (0001758009) (Filer)

    12/15/25 5:06:38 PM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Cingulate Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - Cingulate Inc. (0001862150) (Filer)

    12/15/25 9:14:17 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street initiated coverage on Quantum Computing with a new price target

    Lake Street initiated coverage of Quantum Computing with a rating of Buy and set a new price target of $24.00

    9/18/25 7:59:36 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Cantor Fitzgerald initiated coverage on Quantum Computing with a new price target

    Cantor Fitzgerald initiated coverage of Quantum Computing with a rating of Neutral and set a new price target of $15.00

    7/2/25 7:58:00 AM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    D. Boral Capital reiterated coverage on GeoVax Labs with a new price target

    D. Boral Capital reiterated coverage of GeoVax Labs with a rating of Buy and set a new price target of $14.00 from $18.00 previously

    4/15/25 7:54:48 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Scientific Officer Chaturvedi Pravin R was granted 11,740 shares, increasing direct ownership by 5,929% to 11,938 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    12/15/25 6:02:34 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Bochnowski James J was granted 6,363 shares, increasing direct ownership by 12,237% to 6,415 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    12/15/25 5:57:47 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Siegel Jonathan B. was granted 7,377 shares, increasing direct ownership by 16,037% to 7,423 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    12/15/25 5:52:30 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Financials

    Live finance-specific insights

    View All

    Quantum Computing Inc. Reports Third Quarter 2025 Financial Results

    HOBOKEN, N.J., Nov. 14, 2025 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (NASDAQ:QUBT), an innovative, integrated photonics and quantum optics technology company, today released financial results for the three and nine-month periods ended September 30, 2025. Dr. Yuping Huang, Interim Chief Executive Officer of QCi, commented, "The third quarter marked another important step forward for QCi as we strengthened our balance sheet, deepened commercial and government relationships, and advanced our roadmap toward scalable quantum and photonic manufacturing. Revenues increased 280% year-over-year for the three months ended September 30, 2025, reflecting our sales progress and in

    11/14/25 4:05:00 PM ET
    $QUBT
    Computer Software: Prepackaged Software
    Technology

    Ideal Power Reports Third Quarter 2025 Financial Results

    AUSTIN, Texas, Nov. 13, 2025 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and innovative provider of the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, reports results for its third quarter ended September 30, 2025. "I'm excited to have joined Ideal Power and thrilled by the strong foundation in place for growth. Our first design win customer successfully completed testing of the updated prototype solid-state circuit breakers (SSCBs) and we are currently working with them on the finalization of their first product design," said David Somo, President and Chief Executive Officer of Ideal P

    11/13/25 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology

    Ideal Power to Host Third Quarter 2025 Results Conference Call on November 13, 2025 at 10:00 AM Eastern Time

    AUSTIN, Texas, Nov. 4, 2025 /PRNewswire/ -- Ideal Power Inc. (NASDAQ:IPWR) ("Ideal Power," the "Company," "we," "us" or "our"), developer and innovative provider of the highly efficient and broadly patented B-TRAN® bidirectional semiconductor power switch, today announced that management will hold a conference call on Thursday, November 13, 2025 at 10:00 AM Eastern Time to discuss its results for the third quarter ended September 30, 2025. A press release detailing these results will be issued prior to the call. Ideal Power management will host the conference call, followed by a question-and-answer period. Analysts and investors may pose questions for management during the live conference ca

    11/4/25 9:20:00 AM ET
    $IPWR
    Semiconductors
    Technology

    $AGBA
    $AMPE
    $CING
    $COCH
    Leadership Updates

    Live Leadership Updates

    View All

    Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

    Industry Veteran Bryan Downey Named Chief Commercial Officer NDA Accepted with May 2026 PDUFA Date Commercial Supply Agreement Executed KANSAS CITY, Kan., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to build a pipeline of next-generation products, today announced financial results for the quarter ended September 30, 2025, and provided recent corporate highlights. Recent Highlights (Post-Q3) FDA Accepts NDA for CTx-1301; PDUFA Date Set for May 31, 2026In October of 2025, the U.S. Food and Drug Administration (FDA) accepted Cingulate's New Drug Application

    11/13/25 8:00:00 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cingulate Names Industry Veteran Bryan Downey Chief Commercial Officer to Lead Launch Preparation for CTx-1301

    Appointment builds on recent FDA acceptance of New Drug Application for review and advances Cingulate's transition toward commercialization pending FDA approval Company also strengthens its cash position by completing a $6 million financing KANSAS CITY, Kan., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary Precision Timed Release™ (PTR™) drug-delivery platform, today announced the appointment of Bryan Downey as Chief Commercial Officer, following the U.S. Food and Drug Administration's (FDA) acceptance of Cingulate's New Drug Application (ND

    11/10/25 8:00:00 AM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Envoy Medical Extinguishes over $32 Million in Debt, Strengthening Balance Sheet; Announces Retirement of Glen A. Taylor from Board

    Extinguishment simplifies capital structure, strengthens foundation for growth, and eliminates all term loan obligations, without equity conversionWhite Bear Lake, Minnesota--(Newsfile Corp. - August 26, 2025) - Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced it has satisfied and extinguished the outstanding term loans from GAT Funding, LLC, which totaled $32 million in outstanding principal and accrued interest, in exchange for a payment of $100,000 in cash. GAT Funding is owned by Glen A. Taylor, who also announced his retirement from the Envoy Medical board after two decades of ser

    8/26/25 8:00:00 AM ET
    $COCH
    Industrial Specialties
    Health Care

    $AGBA
    $AMPE
    $CING
    $COCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cingulate Inc.

    SC 13G/A - Cingulate Inc. (0001862150) (Subject)

    11/14/24 7:21:05 PM ET
    $CING
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by GeoVax Labs Inc.

    SC 13G/A - GeoVax Labs, Inc. (0000832489) (Subject)

    11/14/24 5:10:48 PM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Coeptis Therapeutics Holdings Inc.

    SC 13G/A - Coeptis Therapeutics Holdings, Inc. (0001759186) (Subject)

    11/14/24 3:59:49 PM ET
    $COEP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care